CEPS Sells Stake in ICA for £14m, IG Design's Margins Recover, Renalytix Expects Better Second Half, Iomart Forecasts Worsening Losses

CEPS is selling its stake in ICA for £14m, with the disposal requiring shareholder approval. IG Design's margins have recovered, with a raised full-year pre-tax profit estimate to $9.9m. TPXimpact won a £22m NHS contract, while Renalytix expects better second-half revenues and a full-year guidance of $4m. Iomart's trading continues to worsen, with a raised forecast loss to £4.2m.